OpenAlex
PricingAboutJobs
Log inGet started
Author

Pragya Shukla

Observed name: P Shukla
Institution: Thermo Fisher Scientific (Canada)
Observed institution: Thermo Fisher Scientific (Canada)
ORCID: 0000-0001-9372-5630
Observed ORCID: 0000-0001-9372-5630
OpenAlex ID: A5136440492
Transportability of tislelizumab trial outcomes from RATIONALE-315, RATIONALE-303, and RATIONALE-312 to the European population in early-stage non-small cell lung cancer (NSCLC), advanced NSCLC and extensive-stage small cell lung cancer (ES-SCLC)
2026 · Francesco Passiglia, Eugenia Priedane, et al. · Future Oncology
Transportability of tislelizumab trial outcomes from RATIONALE-315, RATIONALE-303, and RATIONALE-312 to the European population in early-stage non-small cell lung cancer (NSCLC), advanced NSCLC and extensive-stage small cell lung cancer (ES-SCLC)
2026 · Francesco Passiglia, Eugenia Priedane, et al. · Figshare
C103-14 Predicting Long-Term Survival Benefit of Nerandomilast in Patients With Idiopathic Pulmonary Fibrosis
2026 · T M Maher, P Pimple, et al. · American Journal of Respiratory and Critical Care Medicine
Works count: 3
Citation count:
H-index:
I10-index:
Year
Topic
Type
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms